OrthoPediatrics (NASDAQ:KIDS) Trading Down 7.2%

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) shares traded down 7.2% during mid-day trading on Friday . The company traded as low as $31.09 and last traded at $31.09. 50,060 shares traded hands during trading, a decline of 72% from the average session volume of 181,675 shares. The stock had previously closed at $33.49.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Needham & Company LLC boosted their price objective on OrthoPediatrics from $37.00 to $42.00 and gave the stock a "buy" rating in a report on Tuesday. JMP Securities reissued a "market outperform" rating and issued a $50.00 price target on shares of OrthoPediatrics in a report on Tuesday. Finally, Truist Financial raised their price objective on shares of OrthoPediatrics from $35.00 to $38.00 and gave the company a "hold" rating in a research report on Wednesday.

OrthoPediatrics Stock Performance

The company has a current ratio of 5.44, a quick ratio of 2.90 and a debt-to-equity ratio of 0.03. The company has a market cap of $739.51 million, a P/E ratio of -34.89 and a beta of 1.16. The company's fifty day moving average is $29.03 and its 200 day moving average is $29.10.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its quarterly earnings data on Wednesday, March 6th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.28) by $0.05. OrthoPediatrics had a negative return on equity of 5.03% and a negative net margin of 14.10%. The firm had revenue of $37.61 million for the quarter, compared to analysts' expectations of $37.59 million. As a group, equities analysts predict that OrthoPediatrics Corp. will post -1.34 earnings per share for the current fiscal year.

Insider Buying and Selling at OrthoPediatrics

In other news, Director Mark C. Throdahl sold 2,433 shares of the firm's stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $27.59, for a total value of $67,126.47. Following the transaction, the director now owns 137,857 shares in the company, valued at $3,803,474.63. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other OrthoPediatrics news, CEO David R. Bailey sold 3,213 shares of the company's stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $27.59, for a total transaction of $88,646.67. Following the completion of the transaction, the chief executive officer now owns 139,384 shares of the company's stock, valued at approximately $3,845,604.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Mark C. Throdahl sold 2,433 shares of OrthoPediatrics stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $27.59, for a total value of $67,126.47. Following the completion of the sale, the director now owns 137,857 shares in the company, valued at $3,803,474.63. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,253 shares of company stock worth $477,375. 31.80% of the stock is currently owned by insiders.

Institutional Investors Weigh In On OrthoPediatrics

Several institutional investors and hedge funds have recently modified their holdings of KIDS. Wellington Management Group LLP bought a new position in OrthoPediatrics in the fourth quarter worth about $10,214,000. Braidwell LP grew its holdings in shares of OrthoPediatrics by 39.0% during the 3rd quarter. Braidwell LP now owns 1,057,770 shares of the company's stock worth $33,849,000 after acquiring an additional 296,562 shares during the period. Granahan Investment Management LLC raised its position in shares of OrthoPediatrics by 30.0% in the 4th quarter. Granahan Investment Management LLC now owns 769,245 shares of the company's stock worth $25,008,000 after acquiring an additional 177,640 shares in the last quarter. Wasatch Advisors LP lifted its stake in shares of OrthoPediatrics by 21.2% in the 1st quarter. Wasatch Advisors LP now owns 501,310 shares of the company's stock valued at $14,618,000 after purchasing an additional 87,657 shares during the period. Finally, Prime Capital Investment Advisors LLC bought a new stake in shares of OrthoPediatrics during the fourth quarter valued at approximately $2,035,000. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.